Invention Grant
US08735135B2 Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them
有权
来自多种药物外排蛋白质缺陷菌株的转化菌株和使用它们的微生物转化方法
- Patent Title: Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them
- Patent Title (中): 来自多种药物外排蛋白质缺陷菌株的转化菌株和使用它们的微生物转化方法
-
Application No.: US12449868Application Date: 2008-02-28
-
Publication No.: US08735135B2Publication Date: 2014-05-27
- Inventor: Tadashi Fujii , Atsushi Ochiai , Masashi Ito , Hiroki Kabumoto , Yoshikazu Fujii , Kazuhiro Machida
- Applicant: Tadashi Fujii , Atsushi Ochiai , Masashi Ito , Hiroki Kabumoto , Yoshikazu Fujii , Kazuhiro Machida
- Applicant Address: JP Tokyo
- Assignee: Microbiopharm Japan Co., Ltd
- Current Assignee: Microbiopharm Japan Co., Ltd
- Current Assignee Address: JP Tokyo
- Agency: Jacobson Holman PLLC
- Priority: JP2007-050935 20070301
- International Application: PCT/JP2008/053565 WO 20080228
- International Announcement: WO2008/105513 WO 20080904
- Main IPC: C12N1/21
- IPC: C12N1/21 ; C12P1/04

Abstract:
Disclosed is a means for improving the poor conversion efficiency in a conventional bioconversion system using a transformant which is given by introducing a gene originated from xerogenic organisms. A transformant is prepared by using a host which is defective in a gene encoding a multidrug efflux protein and introducing a gene originated from xerogenic organisms. Use of the transformant results in much effective microbial conversion of a hydrophobic or amphipathic substrate compound into a desired compound. In case, an Escherichia coli is used as the host, the gene encoding a multidrug efflux protein to be defective may be tolC, acrA, acrB and the like.
Public/Granted literature
Information query
IPC分类: